Advanced HIV
Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997 2007
... with advanced HIV disease compared to patients aged <30 years, but patients aged >50 years were ...an HIV test because of a perceived risk, but then delay presenting to care to avoid ...
8
Cardiovascular disease risk among Chinese antiretroviral naïve adults with advanced HIV disease
... with HIV in our study, prevalence of hypertension and overweight/obes- ity were notably lower that that reported in the general ...of advanced HIV disease status, as evidenced by the low mean CD4+ T ...
10
Role of interferon gamma release assays in the diagnosis of pulmonary tuberculosis in patients with advanced HIV infection
... Our study has several potential limitations. First, the proportion of indeterminate results is higher than in previous studies despite stringent quality control proce- dures. Higher background levels of non-specific ...
7
Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa
... with advanced HIV, accounting for 15–20% of global AIDS-related deaths [6, ...with advanced disease includes CrAg screening for individuals with a CD4 count < 100 followed by fluconazole for CrAg ...
8
“Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets”
... in HIV infected and uninfected ...by HIV status or ethnic ...in advanced HIV ...in HIV negative individ- uals who presented with various other infectious dis- ...by HIV status, ...
13
Subpopulations of long lived and short lived T cells in advanced HIV 1 infection
... The immune system may be divided into populations of cells that are functionally and kinetically distinct: long-lived progenitor cells with the capacity to pro- duce many progeny and end-stage effector cells des- tined ...
12
Utility of interferon γ ELISPOT assay responses in highly tuberculosis exposed patients with advanced HIV infection in South Africa
... WBA (memory) responses. In contrast, ELISPOT responses in HIV+ patients with no history of TB treat- ment did not significantly differ from those of HIV- con- trols. Collectively, these observations suggest ...
9
HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study
... with advanced HIV disease were significantly associated with male sex, older age, migrant workers, divorced or widowed, primary/no education, blood testing of blood receivers and diagnosed HIV in ...
10
Serum concentration of anti Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi
... with advanced HIV infection, high serum concentration of anti-CMV IgG is not independently associated with ...in HIV-infected individuals before advocating the use of specific anti-CMV drugs for ...
10
Wellbeing among sub-Saharan African patients with advanced HIV and/or cancer: an international multicentred comparison study of two outcome measures
... comparing HIV and cancer patients, which suggests that services can ap- proach both populations with a similar care and thus avoid the “silo” approach of providing separate oncology and HIV palliative care ...
8
A workforce in jeopardy identifying the challenges of ensuring a sustainable advanced HIV nursing workforce
... Just over one third (8/21) of the stage 2 nurses were qualified to masters level with the most recently qualified completing a generic Master's degree in Advanced Nursing Practice. They reported a variable degree ...
14
Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa
... enrolled HIV-infected adults and children who were 5 years of age or older, who had not received previous ART, and who had a CD4+ count of fewer than 100 cells per cubic ...of HIV, or had any contra- ...
13
Temporal trend of the proportion of patients presenting with advanced HIV in French Guiana: stuck on the asymptote?
... with advanced disease at the time of diag- nosis thus seems to converge to around 30% (in Greece it seems to have approached 20% [18]) of the total num- ber of diagnosed patients, despite very different ...
6
Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
... enrolled HIV-infected adults and children who were 5 years of age or older, who had not received previous ART, and who had a CD4+ count of fewer than 100 cells per cubic ...of HIV, or had any contra- ...
14
The costs of providing antiretroviral therapy services to HIV infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies
... Tanzania, HIV is managed largely from primary care ...of HIV-infection should have beeen offered ART if they had a CD4 count 350 cells/mm 3 or if they were at WHO clinical stages 3 or 4 ...with ...
16
Enhanced prophylaxis with antiretroviral therapy for advanced HIV in Africa
... One of the limitations of our trial is that we tested an antimicrobial prophylaxis package, which made it difficult to quantify the effect of each component. In the enhanced-prophylaxis group, the rates of death and ...
14
Comparative study of Chest X-Ray features in Pulmonary Tuberculosis With and Without HIV Co-Infection
... both HIV and tuberculosis is rising. The HIV virus damages the body natural defenses – the immune system – and accelerates the speed at which TB progresses from a harmless infection to a life threatening ...
66
PubMedCentral-PMC4931281.pdf
... was later found to be ineligible and was discontinued at day 10 due to having a screening CD4 count value ≥ 50 cells/mm 3 . Participants were enrolled at 18 sites in 10 countries (Malawi, South Africa, Haiti, Kenya, ...
24
Fascicular hypoglossus nerve lesion
... with advanced HIV infection on highly active antiretroviral therapy (HAART), using standard neuropsychological testing in three visits, over a ...of HIV ⫹ par- ticipants over ...
5
Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients
... with advanced HIV-1 infection demonstrated that study participants receiv- ing ganciclovir had a risk reduction of 49% for development of CMV disease compared with those randomized to placebo (Kaplan-Meier ...
7